Subscribe to RSS
Featured Cannabis News
THC in cannabis may reduce nightmares in people with PTSD
The main psychoactive component of cannabis seems to reduce persistent and distressing nightmares in people with post-traumatic stress disorder (PTSD). The drug dronabinol – purified tetrahydrocannabinol (THC) oil extracted from cannabis plants – was more than twice as likely to lead to a complete cessation of nightmares in people with the mental health condition than a placebo. Although it is unclear why it has this effect, THC may suppress the stage of sleep when dreams are most likely to occur.
New Scientist Aug, 14, 2026Data is Becoming Cannabis’ Most Valuable Crop
For more than a decade now, the world’s largest retail conglomerates have been quietly building their consumer data empires. Today, their consumers’ data is perhaps more valuable to these brands than the goods they want to sell them.
Business Of Cannabis Aug.13, 2026Global Cannabis Use Up 40% Over Last Decade as Reform Spreads, but Overlap With Illicit Market Growing
Use of cannabis across the globe has grown by 40% over the last decade, with 256m people now reported to have used cannabis over the past year in 2024.
That growth, according to the United Nations Office on Drugs and Crime‘s World Drug Report 2026 (WDR26), follows a ‘continuum of gradual normalisation’ towards cannabis use, which in turn has helped drive a fragmented, but expanding wave of policy liberalisation.
Federal government invests $24 million for cannabis and brain health research
TORONTO — Federal Minister of Health Marjorie Michel has announced $24 million to create the Canadian Cannabis and Brain Health Consortium.
Funded through the Canadian Institutes of Health Research, the group of 10 research teams from across Canada will work together to study how cannabis affects the brain in people of various ages.
CTV News Aug.12, 2026